8-K: Rayonier Advanced Materials Reports Full Year 2023 Results and Provides Improved 2024 Outlook

Rayonier Advanced Materials reported a net loss of $102 million for 2023, but anticipates improved results for 2024 with an adjusted EBITDA guidance of $180 to $200 million.

Summary

• Rayonier Advanced Materials (RYAM) announced its financial results for the fourth quarter and full year 2023, with net sales for 2023 reaching $1,643 million, a decrease of $74 million from the previous year.
• The company experienced a loss from continuing operations of $102 million in 2023, which included a $62 million non-cash impairment, a decrease of $75 million compared to the prior year.
• Adjusted EBITDA for 2023 was $139 million, and the company generated $53 million in adjusted free cash flow.
• RYAM remained compliant with its debt covenants, with a net secured debt ratio of 4.2 times.
• For 2024, the company projects an adjusted EBITDA of $180 to $200 million and free cash flow of $20 to $40 million.
• The company's 2023 results were impacted by soft demand for cellulose ethers, lower paperboard demand, and weak pricing in high-yield and commodity pulp products.
• Cost-cutting measures and strategic downtime were implemented in response to weaker markets.
• The company expects improved results in 2024 due to higher pricing for cellulose specialties, lower production costs, and the start of operations at its new bioethanol facility.
• The bioethanol facility is expected to contribute $4 million of EBITDA in 2024, growing to $8 to $10 million beginning in 2025.

Sentiment

Score: 5

Explanation: The document presents a mixed picture. While the 2023 results were poor, the company is projecting improved results for 2024 and is taking steps to improve its financial position. The sentiment is neutral to slightly positive due to the forward-looking guidance.

Positives

• The company expects improved results for 2024, with an adjusted EBITDA guidance of $180 to $200 million.
• The new bioethanol facility is expected to contribute to earnings starting in 2024.
• The company anticipates higher pricing for key cellulose specialties products.
• Lower unit production costs are expected for the High Purity Cellulose business.
• Paperboard and High-Yield Pulp are expected to deliver improved results due to lower costs and higher production.
• The company remained in compliance with its debt covenants.
• The company is focusing on generating free cash flow.

Negatives

• The company experienced a net loss of $102 million in 2023.
• 2023 EBITDA results fell short of expectations due to soft demand and weak pricing.
• The company recorded a $62 million non-cash impairment in the fourth quarter of 2023.
• Net sales decreased by $74 million in 2023 compared to the prior year.
• The company experienced lower sales volumes in cellulose specialties and paperboard due to customer destocking and market-driven demand declines.
• High-Yield Pulp sales were significantly down due to lower demand.

Risks

• The company's business is subject to macroeconomic and industry risks, including geopolitical conflicts and pandemics.
• The company operates in highly competitive and cyclical markets, which may result in fluctuations in pricing and volume.
• Changes in the availability and price of raw materials and energy could have a material adverse effect on the company's business.
• The company is subject to risks associated with doing business outside of the United States, including foreign currency exchange fluctuations.
• The company's ten largest customers represent a significant portion of revenue, and the loss of any of these customers could have a material adverse effect.
• A material disruption at any of the company's manufacturing plants could prevent the company from meeting customer demand.
• The company has debt obligations that could materially adversely affect its business and its ability to meet its obligations.
• The company may require additional financing in the future, which may not be available on favorable terms.

Future Outlook

The company anticipates improved results for 2024, with an adjusted EBITDA guidance of $180 to $200 million and free cash flow of $20 to $40 million. The company expects higher pricing for cellulose specialties, lower production costs, and the start of operations at its new bioethanol facility to contribute to improved performance.

Management Comments

• Our primary focus shifted to generating free cash flow, driven predominantly by improvements in working capital and adhering to our lending commitments, said De Lyle Bloomquist, RYAMs President and Chief Executive Officer.
• With an improving outlook aided by a competitors closure, coupled with our sales priority of value over volume, we anticipate better results for 2024, concluded Mr. Bloomquist.

Industry Context

The company's performance is affected by broader industry trends such as construction activity, demand for paperboard, and pricing for pulp products. The closure of a competitor's facility is expected to positively impact RYAM's sales volumes. The company is also investing in new products targeting the green energy and products markets, which aligns with the growing trend of sustainability.

Comparison to Industry Standards

• The company's 2023 performance was impacted by market conditions, including soft demand for cellulose ethers, which is a common challenge in the specialty chemicals industry.
• The company's focus on cost-cutting and strategic downtime is a typical response to market downturns, similar to actions taken by other companies in the pulp and paper sector.
• The company's debt ratio of 4.2 times is within the range of other companies in the industry, but the company is focused on reducing leverage.
• The company's investment in a bioethanol facility is a strategic move to diversify its product portfolio and tap into the growing market for renewable energy, similar to other companies in the sector exploring bio-based alternatives.
• Comparible companies include those in the specialty cellulose, pulp and paper, and biomaterials sectors, such as International Paper, Domtar, and Eastman Chemical, although RYAM's specific product mix and focus on high-purity cellulose make direct comparisons challenging.

Stakeholder Impact

• Shareholders may be concerned about the net loss in 2023 but may be encouraged by the improved outlook for 2024.
• Employees may be affected by cost-cutting measures and strategic downtime.
• Customers may experience changes in pricing and availability of products.
• Suppliers may be affected by changes in demand and pricing.
• Creditors may be concerned about the company's debt obligations but may be reassured by the company's compliance with debt covenants.

Next Steps

• The company will continue to explore the potential sale of its Paperboard and High-Yield Pulp assets.
• The company will commission its bioethanol facility in the first quarter of 2024.
• The company will continue to implement its biomaterials strategy and invest in new products.
• The company will host a conference call on February 28, 2024, to discuss the results.

Key Dates

Keywords

cellulose specialties, EBITDA, free cash flow, high purity cellulose, paperboard, high-yield pulp, bioethanol, debt, net sales, impairment